These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34116645)

  • 1. Is therapeutic inertia present in hyperglycaemia, hypertension and hypercholesterolaemia management among adults with type 2 diabetes in three health clinics in Malaysia? a retrospective cohort study.
    Chew BH; Hussain H; Supian ZA
    BMC Fam Pract; 2021 Jun; 22(1):111. PubMed ID: 34116645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical inertia in type 2 diabetes management in a middle-income country: A retrospective cohort study.
    Wan KS; Moy FM; Mohd Yusof K; Mustapha FI; Mohd Ali Z; Hairi NN
    PLoS One; 2020; 15(10):e0240531. PubMed ID: 33035261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment intensification and therapeutic inertia of antihypertensive therapy among patients with type 2 diabetes and hypertension with uncontrolled blood pressure.
    Wan KS; Moy FM; Mohd Yusoff MF; Mustapha F; Ismail M; Mat Rifin H; Yoga Ratnam KK; Ismail H; Chong KK; Ahmad NA; Hairi NN
    Sci Rep; 2024 Jun; 14(1):12625. PubMed ID: 38824234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in Denmark.
    Safai N; Carstensen B; Vestergaard H; Ridderstråle M
    BMJ Open; 2018 Mar; 8(3):e019214. PubMed ID: 29550776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world evaluation of care for type 2 diabetes in Malaysia: A cross-sectional analysis of the treatment adherence to guideline evaluation in type 2 diabetes (TARGET-T2D) study.
    Lim LL; Hussein Z; Noor NM; Raof ASA; Mustafa N; Bidin MBL; Ghani RA; Samsuddin S; Yong SL; Foo SH; Raghuram K; Suwannasri P; W B WM; Chiew TK; Chan SP
    PLoS One; 2024; 19(1):e0296298. PubMed ID: 38166049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial.
    Frias J; Virdi N; Raja P; Kim Y; Savage G; Osterberg L
    J Med Internet Res; 2017 Jul; 19(7):e246. PubMed ID: 28698169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.
    Mata-Cases M; Benito-Badorrey B; Roura-Olmeda P; Franch-Nadal J; Pepió-Vilaubí JM; Saez M; Coll-de-Tuero G;
    Curr Med Res Opin; 2013 Nov; 29(11):1495-502. PubMed ID: 23944631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inertia and treatment compliance in patients with type 2 diabetes in primary care].
    López-Simarro F; Brotons C; Moral I; Cols-Sagarra C; Selva A; Aguado-Jodar A; Miravet-Jiménez S
    Med Clin (Barc); 2012 Apr; 138(9):377-84. PubMed ID: 22036458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of inertia with lipid-lowering treatment in patients with type 2 diabetes mellitus.
    García Díaz E; Ramírez Medina D; Morera Porras ÓM; Cabrera Mateos JL
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Apr; 66(4):223-231. PubMed ID: 30541682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline treatments and metabolic control of 288,913 type 2 diabetes patients in a 10-year retrospective cohort in Malaysia.
    Wan KS; Mustapha F; Chandran A; Ganapathy SS; Zakariah N; Ramasamy S; Subbarao GR; Mohd Yusoff MF
    Sci Rep; 2023 Oct; 13(1):17338. PubMed ID: 37833402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in the achievement of HbA
    Bakke Å; Dalen I; Thue G; Cooper J; Skeie S; Berg TJ; Jenum AK; Claudi T; Fjeld Løvaas K; Sandberg S
    Diabet Med; 2020 Sep; 37(9):1471-1481. PubMed ID: 31651045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated With Achievement of Blood Pressure, Low-Density Lipoprotein Cholesterol (LDL-C), and Glycemic Targets for Primary Prevention of Cardiovascular Diseases Among High Cardiovascular Risk Malaysians in Primary Care.
    Baharudin N; Ramli AS; Ramland SS; Badlie-Hisham NI; Mohamed-Yassin MS
    J Prim Care Community Health; 2023; 14():21501319231191017. PubMed ID: 37551146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents.
    Ampudia-Blasco FJ; Palanca A; Trillo JL; Navarro J; Real JT
    J Diabetes Complications; 2021 Mar; 35(3):107828. PubMed ID: 33436143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A machine learning model to predict therapeutic inertia in type 2 diabetes using electronic health record data.
    McDaniel CC; Lo-Ciganic WH; Huang J; Chou C
    J Endocrinol Invest; 2024 Jun; 47(6):1419-1433. PubMed ID: 38160431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.
    Whyte MB; Hinton W; McGovern A; van Vlymen J; Ferreira F; Calderara S; Mount J; Munro N; de Lusignan S
    PLoS Med; 2019 Oct; 16(10):e1002942. PubMed ID: 31589609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes-related complications, glycemic levels, and healthcare utilization outcomes after therapeutic inertia in type 2 diabetes mellitus.
    McDaniel CC; Lo-Ciganic WH; Chou C
    Prim Care Diabetes; 2024 Apr; 18(2):188-195. PubMed ID: 38185576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycaemic, blood pressure and low-density lipoprotein-cholesterol control among patients with diabetes mellitus in a specialised clinic in Botswana: a cross-sectional study.
    Mwita JC; Francis JM; Omech B; Botsile E; Oyewo A; Mokgwathi M; Molefe-Baikai OJ; Godman B; Tshikuka JG
    BMJ Open; 2019 Jul; 9(7):e026807. PubMed ID: 31340960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Retrospective Analysis of Therapeutic Inertia in Type 2 Diabetes Management Across a Diverse Population of Health Care Organizations in the USA.
    Rattelman CR; Ciemins EL; Stempniewicz N; Mocarski M; Ganguly R; Cuddeback JK
    Diabetes Ther; 2021 Feb; 12(2):581-594. PubMed ID: 33460018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population attributable fractions of modifiable risk factors for microvascular complications of type 2 diabetes in China: An analysis using national cross-sectional data.
    Lin C; Zhu X; Jiao R; Cai X; Hu S; Lv F; Yang W; Li Z; Ji L
    Diabetes Obes Metab; 2023 Apr; 25 Suppl 1():5-12. PubMed ID: 36811222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.